Technology Transfer: Choosing the Right Model

Joseph Allen, technology transfer expert and President, Joseph Allen and Associates, speaks at the Fourth Annual Celebration of Technology and Innovation at Emory University. In this segment Allen describes the two main schools of thought re government management and sponsorship of research.

About Joseph Allen

Joseph Allen, President, Joseph Allen and Associates: "30 Years of U.S. Technology Policy in 30 Minutes (Along with Thoughts on the Future)"

Joseph Allen is a 30-year veteran of national efforts to foster public/private sector commercialization partnerships. He served as a professional staff member on the U.S. Senate Judiciary Committee with former Senator Birch Bayh (D-In) and was the key staffer securing passage of the Bayh-Dole Act, opening up collaborations between research universities and U.S. industry. In 1999 the Association of University Technology Managers awarded Allen the prestigious Bayh-Dole Award for this achievement. He created the consulting firm Joseph Allen and Associates in 2008, and his clients include the Association of University Technology Managers and the Biotechnology Industry Organization.

About Technology Transfer at Emory University

Emory University's technology transfer program has one of the most robust product pipelines of any university in the country, with one of the nation's leading programs for guiding technology developed in the laboratory through the patenting and licensing process to the marketplace and into the hands of consumers and patients. Since the 1990s, Emory has received more than $775 million in licensing revenues from drugs, diagnostics, devices and consumer products.

The technology transfer program has resulted in 27 licensed therapeutic products, medical devices, and diagnostics already in the marketplace and 12 more in human clinical trials. Emory has launched 47 start-up companies resulting from licensed discoveries. The most widely used drugs for HIV/AIDS, diagnostic tests for genetic disorders, drugs for cancer, a technology to improve angioplasty, and imaging software for diagnosing cardiovascular disease are among the many Emory discoveries now commercially available for patients and physicians.

For more information, see http://www.ott.emory.edu

Category:

Science & Technology

Tags:

• joseph allen
• emory university
• office of technology transfer
• technology transfer
• innovation
• commercialization
• bob dole
• birch bayh
• bayh-dole act
• academic research
• sponsored research
• basic science